Short description
Reviva Pharmaceuticals is a clinical-stage pharmaceutical company developing innovative therapies.
Description
Reviva Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing significant unmet medical needs and burden to society, patients, and their families. Reviva’s current pipeline focuses on the central nervous system, respiratory, and metabolic diseases. Reviva is using chemical genomics driven technology platform and proprietary chemistry to develop new medicines. Reviva’s pipeline currently has two drug candidates, RP5063 (Brilaroxazine) and RP1208. Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both RP5063 and R1208 in the United States (U.S.), Europe, and several other countries.
Last funding
No Way
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
San Jose, California, United States, North America
Founded on
January 1, 2006
Exited on
December 15, 2020
Went public on
December 15, 2020
Stock symbol
RVPH
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Founders
Laxminarayan Bhat